References
- Lennard-Jones JE. Sulphasalazine, corticosteroids, and immunosuppressive drugs in the treatment of inflammatory bowel diseases. Inflammatory bowel diseases, R N Allan, M RB Keighly, J Alexander-Williams, C Hawkins. Churchill Livingstone, New York 1983
- Löfberg R, Danielsson Å, Salde L. Oral budesonide in active ileocecal Crohn's disease. Aliment Pharmacol Ther 1993; 7: 611–6
- Danielsson Å, Löfberg R, Persson T, Salde L, Schiöler R, Suhr O, et al. A steroid enema, budesonide, lacking systemic effects for the treatment of distal ulcerative colitis or proctitis. Scand J Gastroenterol 1992; 27: 9–12
- Greenberg G R, Feagan B G, Martin F, Sutherland L R, Thomson A B, Williams C N, et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994; 331: 836–41
- Boyd A J, Sherman I A, Saibil FG. Microcirculation in trinitrobenzene sulphonic acid-induced ileitis. Gastroenterology 1993; 104: A-1030
- Mullane K M, Kraemer R, Smith B. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharm Meth 1985; 14: 157–67
- Weinberg J, Wong R. Consummatory behaviour and adrenocortical responsiveness in the hamster. Physiol Behav 1983; 31: 7–12
- Knutson L, Ahrenstedt O, Odlind B, Hallgren R. The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology 1990; 98: 849–54
- Dvorak A M, Monahan RA. Crohn's disease-mast cell quantitation using one micron plastic sections for light microscopy. Pathol Annu 1983; 18: 181–90
- Rao SN. Mast cells as a component of the granuloma in Crohn's disease. J Pathol 1973; 109: 79–82
- Ranlov P, Neilsen M H, Wanstrup J. infrastructure of the ileum in Crohn's disease. Immune lesions and mastocytosis. Scand J Gastroenterol 1972; 7: 471–6
- King S J, Miller H R, Newlands G F, Woodbury RG. Depletion of mucosal mast cell protease by corticosteroids: effect on intestinal anaphylaxis in the rat. Proc Nat Acad Sci (USA) 1985; 82: 1214–8
- Hawthorne A B, Hawkey CJ. Immunosuppressive drugs in inflammatory bowel disease: a review of their mechanisms of efficacy and place in therapy. Drugs 1989; 38: 267–88
- Brattsand R. Overview of newer glucocorticosteroid preparations for the treatment of inflammatory bowel disease. Can J Gastroenterol 1990; 4: 241–52
- Rutgeerts P, Löfberg R, Malchow H, Lamers C, Olaison G, Jewell D, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994; 331: 842–5